Thursday - April 23, 2026

Category Archives: Science

Hepatocellular Carcinoma Clinical Trial Pipeline Expands as 90+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Hepatocellular Carcinoma Pipeline Insight 2026 report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in the Hepatocellular Carcinoma pipeline landscape. It covers the Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Diabetic Macular Edema Clinical Trial Pipeline Shows Potential with Active Contributions from 45+ Key Companies | DelveInsight

DelveInsight’s “Diabetic Macular Edema Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Diffuse Large B-Cell Lymphoma Clinical Trial Pipeline Gains Momentum: 70+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insights 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline landscape. It covers the Diffuse Large B-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical … Continue reading →

HER2-Negative Breast Cancer Clinical Trial Pipeline Accelerates as 70+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “HER2-Negative Breast Cancer Pipeline Insight 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in HER2-Negative Breast Cancer pipeline landscape. It covers the HER2-Negative Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Dayhoff Health Reports 330× Increase in Microbiome Processing Speed Through AMD GPU Acceleration

GPU and Genomics Breakthrough Dayhoff Health and AMD publish a joint white paper documenting up to 330× faster microbiome processing, 13–22× faster whole genome sequencing, and 18–28× faster single-cell sequencing using AMD Radeon™ AI PRO R9700 GPUs. Results support high-throughput … Continue reading →

Neurofibromatosis Type 2 Treatment Pipeline Shows Strong Momentum as 5+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Neurofibromatosis Type 2 Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Neurofibromatosis Type 2 pipeline landscape. It covers the Neurofibromatosis Type 2 Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

HPV+ Recurrent/Metastatic Head and Neck Cancer Clinical Trial Pipeline Expands as 5+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “HPV+ Recurrent/Metastatic Head and Neck Cancer Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the HPV+ Recurrent/Metastatic Head and Neck Cancer pipeline landscape. It covers the HPV+ Recurrent/Metastatic Head and Neck Cancer … Continue reading →

Catheter-Related Bloodstream Infections Clinical Trial Pipeline Shows Potential with Active Contributions from 5+ Key Companies | DelveInsight

DelveInsight’s “Catheter-Related Bloodstream Infections Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Catheter-Related Bloodstream Infections pipeline landscape. It covers the Catheter-Related Bloodstream Infections Pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →